AQST FY 2022 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$431M

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$48M-6.2% YoY

Gross Profit

$28M59.3% margin

Operating Income

-$42M-88.2% margin

Net Income

-$54M-114.1% margin

EPS (Diluted)

$-1.12

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$12M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$57M

Total Liabilities

$176M

Stockholders' Equity

-$119M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$51M	-6.2%
Gross Profit	$28M	$36M	-21.1%
Operating Income	-$42M	-$35M	-21.3%
Net Income	-$54M	-$71M	+22.9%